| Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ... Indian Journal of Medical Research 152 (1-2), 48-60, 2020 | 211 | 2020 |
| SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey MV Murhekar, T Bhatnagar, S Selvaraju, V Saravanakumar, ... The Lancet Global Health 9 (3), e257-e266, 2021 | 191 | 2021 |
| SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... International Journal of Infectious Diseases 108, 145-155, 2021 | 124 | 2021 |
| Efficacy and safety of once-daily nevirapine-or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial S Swaminathan, C Padmapriyadarsini, P Venkatesan, G Narendran, ... Clinical Infectious Diseases 53 (7), 716-724, 2011 | 87 | 2011 |
| Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... PLoS medicine 18 (12), e1003877, 2021 | 61 | 2021 |
| Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD AN Gupte, M Paradkar, S Selvaraju, K Thiruvengadam, SVBY Shivakumar, ... PloS one 14 (5), e0217289, 2019 | 53 | 2019 |
| Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India … P Thekkur, AMV Kumar, P Chinnakali, S Selvaraju, R Bairy, AR Singh, ... Global health action 12 (1), 1568826, 2019 | 47 | 2019 |
| Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A … B Velayutham, VK Chadha, N Singla, P Narang, V Gangadhar Rao, ... PLoS One 13 (7), e0200150, 2018 | 45 | 2018 |
| Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study A Gupte, C Padmapriyadarsini, V Mave, D Kadam, N Suryavanshi, ... BMJ open 6 (2), e010542, 2016 | 39 | 2016 |
| Changes in acute encephalitis syndrome incidence after introduction of Japanese encephalitis vaccine in a region of India P Ranjan, M Gore, S Selvaraju, KP Kushwaha, DK Srivastava, ... Journal of Infection 69 (2), 200-202, 2014 | 35 | 2014 |
| Population-based serosurvey for severe acute respiratory syndrome coronavirus 2 transmission, Chennai, India S Selvaraju, MS Kumar, JWV Thangaraj, T Bhatnagar, V Saravanakumar, ... Emerging Infectious Diseases 27 (2), 586, 2021 | 30 | 2021 |
| Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India PK Moonan, SA Nair, R Agarwal, VK Chadha, PK Dewan, UD Gupta, ... BMJ global health 3 (5), e001135, 2018 | 25 | 2018 |
| Non-communicable disease comorbidities and risk factors among tuberculosis patients, Meghalaya, India B Marak, P Kaur, SR Rao, S Selvaraju indian journal of tuberculosis 63 (2), 123-125, 2016 | 24 | 2016 |
| Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy? CK Dolla, C Padmapriyadarsini, K Thiruvengadam, R Lokhande, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 113 (10 …, 2019 | 23 | 2019 |
| Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013 MV Murhekar, P Ranjan, S Selvaraju, A Pandey, MM Gore, ... Journal of Infection 69 (5), 517-520, 2014 | 21 | 2014 |
| Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India M Paradkar, C Padmapriyadarsini, D Jain, SVBY Shivakumar, ... PLoS One 15 (7), e0236743, 2020 | 20 | 2020 |
| Long-term survival of treated tuberculosis patients in comparison to a general population in South India: a matched cohort study S Selvaraju, K Thiruvengadam, B Watson, N Thirumalai, M Malaisamy, ... International Journal of Infectious Diseases 110, 385-393, 2021 | 19 | 2021 |
| Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting B Velayutham, L Jayabal, B Watson, S Jagadeesan, D Angamuthu, ... Plos one 15 (10), e0240594, 2020 | 19 | 2020 |
| TBDRUGS-Database of drugs for tuberculosis. JC Sundaramurthi, LE Hanna, S Selvaraju, S Brindha, J Gnanadoss, ... Tuberculosis (Edinburgh, Scotland) 100, 69-71, 2016 | 16 | 2016 |
| Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis AN Gupte, S Selvaraju, M Paradkar, K Danasekaran, S Shivakumar, ... The International Journal of Tuberculosis and Lung Disease 23 (4), 450-457, 2019 | 12 | 2019 |
Kannan ThiruvengadamIndian Council of Medical Researchicmr.gov.in üzerinde doğrulanmış e-posta adresine sahip
